[Meropenem and valproic acid: A clinically relevant drug-drug interaction]

Enferm Infecc Microbiol Clin. 2016 Oct;34(8):536-7. doi: 10.1016/j.eimc.2015.10.008. Epub 2015 Dec 2.

[Article in Spanish]

Authors

Elena Sánchez-Yáñez¹, Clara Estaún-Martínez², Guillermo Ojeda Burgos³

Affiliations

¹ Unidad de Gestión Clínica de Farmacia, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España. Electronic address: esanchezyanez@gmail.com.
² Unidad de Gestión Clínica de Farmacia, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España.
³ Unidad de Gestión Clínica de Medicina Interna, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España.

PMID: 26653178
DOI: 10.1016/j.eimc.2015.10.008

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Bacterial Agents / pharmacology*
Anticonvulsants / blood
Anticonvulsants / pharmacology*
Drug Interactions
Epilepsy / blood
Epilepsy / drug therapy*
Female
Fructose / analogs & derivatives
Fructose / pharmacology
Humans
Meropenem
Peritonitis / drug therapy
Postoperative Complications / drug therapy
Thienamycins / pharmacology*
Topiramate
Valproic Acid / blood
Valproic Acid / pharmacology*

Substances

Anti-Bacterial Agents
Anticonvulsants
Thienamycins
Topiramate
Fructose
Valproic Acid
Meropenem